Maravai LifeSciences Holdings, Inc.
NASDAQ:MRVIBiotechnology
-$0.15 today
- Market cap
- $2.10B
- Beta
- 0.71
- P/E (TTM)
- -7.1
- EPS (TTM)
- -$0.71
Volume 1.41M
Average 2.42M
Balance Sheet
Inspect the capital base behind the business.
Assets
$770.58M
FY 2025 · Annual
-23.6% YoYLiabilities
$397.87M
FY 2025 · Annual
-7.7% YoYEquity
$372.71M
FY 2025 · Annual
-35.4% YoYBalance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 551.27M | 632.14M | 574.96M | 322.4M | 216.89M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 117.51M | 146.81M | 55.72M | 38.52M | 25.5M |
| Inventory | 51.56M | 43.15M | 51.4M | 50.08M | 40.5M |
| Other Current Assets | 0 | 25.8M | 17.83M | 18.15M | 13.37M |
| Total Current Assets | 740.04M | 847.9M | 699.91M | 429.15M | 296.25M |
| Property, Plant & Equipment (Net) | 95.43M | 116.59M | 222.65M | 217.03M | 1.22M |
| Goodwill | 152.77M | 283.67M | 326.03M | 159.88M | 129.43M |
| Intangible Assets | 117.57M | 216.66M | 220.99M | 194.96M | 151.54M |
| Long-term Investments | 0 | 11.36M | 8.56M | 0 | 0 |
| Tax Assets | 808.12M | 765.8M | 0 | 0 | 0 |
| Other Non-current Assets | 4.36M | 40.33M | 9.32M | 7.24M | 192.14M |
| Total Non-current Assets | 1.18B | 1.43B | 787.54M | 579.1M | 474.33M |
| Total Assets | 1.92B | 2.28B | 1.49B | 1.01B | 770.58M |
| Account Payables | 8.15M | 5.99M | 10.73M | 11.96M | 0 |
| Short-term Debt | 6M | 5.44M | 5.44M | 5.44M | 5.44M |
| Tax Payables | 1.4M | 1.03M | 1M | 779K | 24.49M |
| Deferred Revenue | 12.64M | 3.09M | 3.36M | 3.29M | 0 |
| Other Current Liabilities | 18.89M | 69.48M | 47.62M | 18.71M | 39.48M |
| Total Current Liabilities | 93.78M | 110.14M | 87.47M | 56.97M | 44.92M |
| Long-term Debt | 524.59M | 522M | 518.71M | 290.49M | 30.14M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 713.64M | 693.38M | 11.98M | 11.09M | 322.81M |
| Total Non-current Liabilities | 1.28B | 1.27B | 610.1M | 374.06M | 352.95M |
| Total Liabilities | 1.37B | 1.38B | 697.57M | 431.04M | 397.87M |
| Common Stock | 2.55M | 2.55M | 2.51M | 2.53M | 2.56M |
| Retained Earnings | 184.56M | 404.77M | 285.74M | 140.89M | 10.12M |
| Accumulated OCI | 0 | 0 | 0 | 0 | 524K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 229.86M | 360.03M | 373.13M | 251.92M | 160.33M |
| Total Equity | 545.36M | 905.24M | 789.88M | 577.21M | 372.71M |
| Total Debt | 575.22M | 585.26M | 610.97M | 376.69M | 35.58M |
| Net Debt | 23.95M | (46.88M) | 36.01M | 54.29M | (181.31M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $70.1M |
| Receivables | $31.1M |
| Inventory | $41.2M |
| Other Current | $13.2M |
| Total Current Assets | $155.7M |
| PP&E (Net) | $142.4M |
| Goodwill | $129.4M |
| Intangible Assets | $138.4M |
| Other Non-current | $37.9M |
| Total Non-current Assets | $448.1M |
| Total Assets | $603.7M |
Analysis
Selected assets total $603.7M for Latest. The largest visible component is PP&E (Net) at $142.4M, about 23.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Nov 4, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 2, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 9, 2026 |
How much cash does MRVI have?
Maravai LifeSciences Holdings, Inc. (MRVI) reported $216.89M in cash and equivalents in fiscal 2025.
How much debt does MRVI carry?
Maravai LifeSciences Holdings, Inc. (MRVI) reported $35.58M of total debt, with net debt of -$181.31M.
Continue the stock analysis
Jump to another research area for this company.